Ciprofloxacin-Induced Antibacterial Activity Is Attenuated by Phosphodiesterase Inhibitors
- PMID: 26649077
- PMCID: PMC4644238
- DOI: 10.1016/j.curtheres.2014.11.001
Ciprofloxacin-Induced Antibacterial Activity Is Attenuated by Phosphodiesterase Inhibitors
Abstract
Background: Ciprofloxacin is a commonly used antibiotic for urinary tract infection that interacts with bacterial topoisomerases leading to oxidative radicals generation and bacterial cell death. Phosphodiesterase inhibitors (PDEis), on the other hand, are commonly used drugs for the management of erectile dysfunction. The group includes agents such as sildenafil, vardenafil, and tadalafil.
Objectives: We investigated whether PDEi could interfere with the antibacterial activity of ciprofloxacin.
Methods: PDEis were tested in several reference bacteria, including Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Staphylococcus epidermidis, Acinetobacter baumannii, Proteus mirabilis, and Klebsiella pneumoniae utilizing a standard disc diffusion method and measuring both zones of inhibition and MIC.
Results: Results from both assays indicated that ciprofloxacin demonstrates potent activity against the tested reference bacteria. Additionally, when bacteria were treated with a combination of ciprofloxacin and sildenafil, tadalafil, or vardenafil, the zones of the combination inhibition were significantly reduced, whereas the MIC values were significantly greater than those of ciprofloxacin alone for all tested bacterial strains. In an attempt to examine the mechanism by which PDEis interfere with the action of ciprofloxacin, we utilized the in vitro E coli DNA gyrase cleavage assay. The results showed that PDEi drugs had no effect on ciprofloxacin's inhibition of E coli gyrase activity.
Conclusions: Pretreatment of various reference bacterial cells with PDEis largely inhibited the antibacterial activity of ciprofloxacin.
Keywords: MIC; PDEi; antimicrobial susceptibility; ciprofloxacin; sildenafil; tadalafil; vardenafil.
Figures

Similar articles
-
Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin.Clin Pharmacol. 2017 Oct 17;9:119-124. doi: 10.2147/CPAA.S148448. eCollection 2017. Clin Pharmacol. 2017. PMID: 29081676 Free PMC article.
-
Vitamin D Pretreatment Attenuates Ciprofloxacin-Induced Antibacterial Activity.Clin Pharmacol. 2020 Oct 12;12:171-176. doi: 10.2147/CPAA.S268330. eCollection 2020. Clin Pharmacol. 2020. PMID: 33116949 Free PMC article.
-
Ciprofloxacin-Induced Antibacterial Activity Is Atteneuated by Pretreatment with Antioxidant Agents.Pathogens. 2016 Mar 9;5(1):28. doi: 10.3390/pathogens5010028. Pathogens. 2016. PMID: 27005666 Free PMC article.
-
Focus on phosphodiesterase inhibitors for the treatment of erectile dysfunction in older men.Clin Ther. 2011 Nov;33(11):1590-608. doi: 10.1016/j.clinthera.2011.09.029. Epub 2011 Oct 29. Clin Ther. 2011. PMID: 22036514 Review.
-
The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic.Front Public Health. 2022 Dec 21;10:1025633. doi: 10.3389/fpubh.2022.1025633. eCollection 2022. Front Public Health. 2022. PMID: 36620240 Free PMC article. Review.
Cited by
-
Study the Ability of Salmonella typhimiurm to Induce Cytokine TNFα in Mice Treated with Olive Leaves Extract and Ciprofloxacin.Arch Razi Inst. 2022 Oct 31;77(5):1799-1804. doi: 10.22092/ARI.2022.358331.2196. eCollection 2022 Oct. Arch Razi Inst. 2022. PMID: 37123137 Free PMC article.
-
Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin.Clin Pharmacol. 2017 Oct 17;9:119-124. doi: 10.2147/CPAA.S148448. eCollection 2017. Clin Pharmacol. 2017. PMID: 29081676 Free PMC article.
-
Construction of antimicrobial peptide-drug combination networks from scientific literature based on a semi-automated curation workflow.Database (Oxford). 2016 Dec 26;2016:baw143. doi: 10.1093/database/baw143. Print 2016. Database (Oxford). 2016. PMID: 28025336 Free PMC article.
-
Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach.Drug Des Devel Ther. 2016 Oct 12;10:3331-3343. doi: 10.2147/DDDT.S116443. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27784991 Free PMC article.
-
Development of Ciprofloxacin-Loaded Bilosomes In-Situ Gel for Ocular Delivery: Optimization, In-Vitro Characterization, Ex-Vivo Permeation, and Antimicrobial Study.Gels. 2022 Oct 25;8(11):687. doi: 10.3390/gels8110687. Gels. 2022. PMID: 36354595 Free PMC article.
References
-
- Lombardi G., Nelli F., Celso M., Mencarini M., Del Popolo G. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature. J Sex Med. 2012;9:970–985. - PubMed
-
- Smith W.B., 2nd, McCaslin I.R., Gokce A., Mandava S.H., Trost L., Hellstrom W.J. PDE5 inhibitors: considerations for preference and long-term adherence. Int J Clin Pract. 2013;67:768–780. - PubMed
-
- Patel D.N., Li L., Kee C.L., Ge X., Low M.Y., Koh H.L. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges. J Pharm Biomed Anal. 2014;87:176–190. - PubMed
-
- Guzman D.C., Olguin H.J., Brizuela N.O., Garcia E.H., Mejia G.B., Jacobo A.J., Abarca L.S., Betancourt E.T. Effect of prostaglandin E1 (PGE1) and sildenafil on serotonin metabolism and some oxidative damage markers in rat prostate gland and brain. Andrologia. 2011;43:266–272. - PubMed
-
- Puerta E., Barros-Minones L., Hervias I., Gomez-Rodriguez V., Orejana L., Pizarro N., de la Torre R., Jordan J., Aguirre N. Long-lasting neuroprotective effect of sildenafil against 3,4-methylenedioxymethamphetamine- induced 5-hydroxytryptamine deficits in the rat brain. J Neurosci Res. 2012;90:518–528. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources